Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-15

Clinical Trial Update: An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the blood pressure-lowering efficacy and safety of olmesartan medoxomil in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2009-09-15